Phentermine Hydrochloride
NDC 50436-3175
Product Information
Phentermine Hydrochloride is a ANDA-approved product labeled by Unit Dose Services. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a yellow product. This product entry covers the primary NDC 50436-3175 and 6 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
K;27
Code Structure Chart
Product Details
What is NDC 50436-3175?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PHENTERMINE HYDROCHLORIDE (UNII: 0K2I505OTV)
- PHENTERMINE (UNII: C045TQL4WP) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- GELATIN (UNII: 2G86QN327L)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C RED NO. 3 (UNII: PN2ZH5LOQY)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 900038 - phentermine HCl 30 MG Oral Capsule
- RxCUI: 900038 - phentermine hydrochloride 30 MG Oral Capsule
- RxCUI: 900038 - phentermine hydrochloride 30 MG (equivalent to phentermine 24 MG) Oral Capsule
* Please review the full disclaimer at the bottom of this page.
Patient Education
Phentermine
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
[Learn More]
* Please review the full disclaimer at the bottom of this page.